Altered role of smooth muscle endothelin receptors in coronary endothelin-1 and α1-adrenoceptor-mediated vasoconstriction in Type 2 diabetes
Authors:
Open Access
- 1 October 2007
- journal article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 293 (4) , H2281-H2288
Abstract
Regulation of vascular tone and blood flow involves interactions between numerous local and systemic vascular control signals, many of which are altered by Type 2 diabetes (T2D). Vascular responses to endothelin-1 (ET-1) are mediated by endothelin type A (ETA) and type B (ETB) receptors that have been implicated in cross talk with α1-adrenoceptors (α1-AR). ETAand ETBreceptor expression and plasma ET-1 levels are elevated in T2D; however, whether this influences coronary α1-AR function has not been examined. Therefore, we examined the effect of ETAand ETBreceptor inhibition on coronary vasoconstriction to ET-1 and α1-AR activation in a mouse model of T2D. Coronary vascular responses were examined in isolated mouse hearts from control and diet-induced T2D C57BL/6J mice. Responses to ET-1 and the selective α1-AR agonist phenylephrine (PE) were examined alone and in the presence of the nitric oxide synthase inhibitor Nω-nitro-l-arginine methyl ester (l-NAME) alone or in combination with selective ETAor ETBreceptor inhibitors BQ-123 and BQ-788, respectively. Vasoconstriction to ET-1 was enhanced, whereas ETB, but not ETA, receptor blockade reduced basal coronary tone in T2D hearts. In the presence of l-NAME, ETAreceptor inhibition attenuated ET-1 vasoconstriction in both groups, whereas ETBinhibition abolished this response only in control hearts. In addition, ETAinhibition enhanced α1-AR-mediated vasoconstriction in T2D, but not control, hearts following l-NAME treatment. Therefore, in this model, enhanced coronary ET-1 responsiveness is mediated primarily through smooth muscle ETBreceptors, whereas the interaction with α1-ARs is mediated solely through the ETAreceptor subtype.Keywords
This publication has 47 references indexed in Scilit:
- Diet‐induced obesity and diabetes reduce coronary responses to nitric oxide due to reduced bioavailability in isolated mouse heartsDiabetes, Obesity and Metabolism, 2006
- In vivo evidence for endothelin-1-mediated attenuation of α1-adrenergic stimulationAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- ETA and ETB receptors differentially modulate afferent and efferent arteriolar responses to endothelinBritish Journal of Pharmacology, 2005
- Endogenous endothelin attenuates the pressor response to acute environmental stress via the ETAreceptorAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Endothelin-1-induced responses in isolated mouse vessels: the expression and function of receptor typesAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Nitric oxide decreases endothelin-1 secretion through the activation of soluble guanylate cyclaseAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2004
- Heterozygous Knock-Out of ET B Receptors Induces BQ-123–Sensitive Hypertension in the MouseHypertension, 2000
- Endothelin receptor subtypes and their functional relevance in human small coronary arteriesBritish Journal of Pharmacology, 1998
- Endogenous Vasoactive Systems and the Pressor Effect of Acute N ω-Nitro-L-Arginine Methyl Ester AdministrationJournal of Cardiovascular Pharmacology, 1994
- Termination of endothelin signaling: Role of nitric oxideJournal of Cellular Physiology, 1994